What's Hot
View all perspectives
Symplur Hashtags healthhashtags
3 years 1 month ago
Top Influencers of #acr21: @ACRheum @rheum_cat @RheumNow @CreakyJoints @RichardPAConway @KDAO2011 @alhkim More 📊 https://t.co/vyMAwjKbqC
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 1 month ago
*️⃣Abst#1800 observed that a changing pattern of purine, lipid, & amino acid metabolites occurred during transition from PsO to PsA.
*️⃣Compared to pts w/ Pso that didn't progress to PsA, those that progressed had elevated levels of guanine!
Potential biomarkers?
#ACR21 @RheumNow https://t.co/iQh1ZapDMB
Janet Pope Janetbirdope
3 years 1 month ago
Dementia is ⬆️in #RheumatoidArthritis says Elena Myasoedva but #RA has more DM &CV disease which ⬆️dementia. Need to separate vascular dementia from Alzheimer’s. When I trained we thought less dementia in RA -likely not true. More work is coming. 9T213 aging hub #ACR21 @RheumNow
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 1 month ago
Post-Hoc of the ASCORE trial showed the following b/l characteristics were most likely associated with remission (per DAS28, SDAI, CDAI) in mod-severe RA patients treated w/ SQ Abatacept:
⭐️Seropositivity
⭐️no prior bMDARD use
⭐️low HAQ-DI
⭐️low BMI
Abst#1228 #ACR21 @Rheumnow https://t.co/NvJoSWScZs
swethaann23 swethaann23
3 years 1 month ago
⭐️Immune phenotyping of 45 patients with Pso and 41 PsA pts showed a number of cell subsets significantly different in Pso vs PsA
⭐️Future possibility of using a combination of selected immune cell subsets as a method for detecting PsA in Pso pts
Abst#1774 #ACR21 @Rheumnow https://t.co/ER1MPOvMa6
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 1 month ago
#ACR21 #AbstrL17 In pts treated with Rituximab, arrange a 3rd primary dose ASAP regardless mRNA or vector #COVID vaccine. An RCT of N=60 pts who did not seroconvert after primary dose, overall 94% either seroconverted/new T-cell response @RheumNow #ACRBest https://t.co/F15j93OFE4 https://t.co/tXoisoYthx
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 1 month ago
Abst#1774 identified a blood-based immune profile with a machine-learning approach that discriminates PsA from Pso.
➡️↑ proportions of differentiated CD4+CD196+CD183–CD194+ and CD4+CD196–CD183–CD194+ T-cells in PsA
#ACR21 @RheumNow https://t.co/64uhJCd2qo
Dr. John Cush RheumNow
3 years 1 month ago
Fibromyalgianess Glucocorticoid Persistence in RA Patients: Dr. Sheila Reyes ( @RHEUMarampa) discusses abstract #0120 presented at the #ACR21 annual meeting.
https://t.co/9yOM5rSARv https://t.co/Gq2YxbxkmM
Dr. John Cush RheumNow
3 years 1 month ago
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @Novartis. All content chosen by #RheumNow & its Faculty.
Janet Pope Janetbirdope
3 years 1 month ago
Great work from #CATCH cohort. Yes I am biased. @earlyarthritis #ACR21 abst#1661 @RheumNow https://t.co/hogyNEQiWM
Janet Pope Janetbirdope
3 years 1 month ago
#Guselkimab Better than #ustekinumab for skin& MSK. #Ixekizumab beat ustekinumab for skin. #ustekinumab loses throne in #psoriasis and #psoriatic arthritis except maybe if concomitant inflammatory bowel disease post TNFi? Rapidly evolving PsA Rx. Abst#1773 #ACR21 @RheumNow https://t.co/Dkf2DFFsSK
Akhil Sood MD AkhilSoodMD
3 years 1 month ago
COVID 19 Poster Review
Abst 0197
Haibel & colleagues performed open label study on IL-1/IL-6 inhibitor combo
- Majority avoided mechanical ventilation (25/31)
- 2 pts died while on ECMO
- CT Chest findings improved 1 month after treatment
#ACR21 @RheumNow https://t.co/CIJR1Tx8St
Meral K. El Ramahi, MD MeralElRamahiMD
3 years 1 month ago
Post-Hoc of the ASCORE trial showed the following b/l characteristics were most likely associated with remission (per DAS28, SDAI, CDAI) in mod-severe RA patients treated w/ SQ Abatacept:
⭐️Seropositivity
⭐️no prior bMDARD use
⭐️low HAQ-DI
⭐️low BMI
Abst#1228 @ACR21 @Rheumnow https://t.co/LRd1HVbm5B
Akhil Sood MD AkhilSoodMD
3 years 1 month ago
CH COVID 19 Poster Review
Abst 0196
Jackson & colleagues performed double blind RCT of anakinra in patients with features of COVID-19 cytokine storm
- Anakinra + GC did not significantly impact outcomes in patients with cytokine storm syndrome
#ACR21 @RheumNow https://t.co/hX7bBtrIzT
Poster Hall